Goldman Sachs crosses thresholds in Nanobiotix

The Goldman Sachs Group, Inc. crossed the 5% ownership threshold of Nanobiotix's share capital and voting rights on January 19, 2026. This declaration, received on January 23, 2026, indicates that Goldman Sachs now holds 5.39% of Nanobiotix's share capital and 5.21% of its voting rights, representing 2,608,274 shares. The acquisition resulted from an off-market transaction.

Among the entities involved, Goldman Sachs International owns 5.37% of the capital, followed by Goldman Sachs & Co. LLC and other group entities holding negligible stakes. Additional shares are held through securities lending with recall rights and cash-settled swap contracts.

This information, taken into account under the relevant articles of the commercial code, underlines the growing influence of Goldman Sachs on Nanobiotix.